Zhang Chen and the four of them followed Zhao Yingbo to the old man's ward yesterday.

Today, in addition to the young woman, there is another middle-aged man in the ward.

After mutual introduction, it was learned that the middle-aged man was the patient's son.

Due to the patient's inconvenience, Zhao Yingbo chose intravenous injection in the way of administration.

Immediately after administering the medicine, the nurses began to carry out various examinations.

The results of the first examination were similar to those of the time when the drug was not administered.

However, after 10 minutes, the second test was done and there was a significant difference in the data compared to before the administration.

The overall results show that within a very short period of time after administration, patients show a trend towards a healthy state.

In the 20th minute, another check was done.

The results showed that most of the cardiovascular diseases that had plagued the patients for many years were relieved.

Another 10 minutes passed, under the expectant eyes of everyone.

The results of the fourth inspection are finally in.

The results of the laboratory tests clearly proved that the old man's cardiovascular disease was completely cured.

Zhang Yingbo's eyes widened, looking at the inspection report in front of her, she couldn't believe it at all.

In his opinion, such a result is a bit too magical.

In half an hour, an elderly patient with more than ten years of cardiovascular disease was completely cured.

And according to its efficacy, there will be no recurrence of any cardiovascular-related disease in the future.

With such an effect, it is not an exaggeration to say that this medicine is a panacea.

Of course, whether there is a preventive effect or not depends on the follow-up physical tests.

From all the results that have come out so far, it can be seen that the old man's cardiovascular disease has been completely cured, and he can be discharged from the hospital directly.

This reminded Zhao Yingbo of one thing, when Zhang Guoyuan was hospitalized for a heart attack.

It must have been Zhang Chen who used this miraculous gene therapy drug in private, so he was directly cured in a very short period of time.

Originally, he had to go to the operating table to make a heart stent to be rescued, but Zhang Chen used such a miraculous medicine to save him directly.

After that, Zhang Guoyuan also came to the People's Hospital for two examinations in accordance with the requirements of the re-examination.

Zhao Yingbo personally accompanied these inspections throughout the process.

Finally, it was shown that Zhang Guoyuan had no potential risk of recurrent cardiovascular disease at all.

In fact, it can be seen from Zhang Guoyuan that this drug can indeed effectively prevent the occurrence of such diseases.

"Mr. Zhang, your medicine is amazing, I can't wait for all patients to use it immediately!"

Zhao Yingbo said excitedly.

"In fact, I also want all cardiovascular patients to use it as soon as possible, but the process that should be gone still has to be followed, and this drug needs to go through the entire process of clinical trials."

Zhang Chen said: "But fortunately, cardiovascular disease, in general, is not a very acute disease, there is no need to ignore the national policy in order to rush this time, so that people can use safe drugs is the most important thing." ”

Zhao Yingbo nodded, "I'm just a little excited." ”

After speaking, he passed the test results in his hand to everyone and patiently explained on the side.

There was no happiest woman than the young woman, who had a very good relationship with her grandfather.

Now that she saw that the cardiovascular disease that had plagued her grandfather for many years had been completely cured, she was so excited that she almost jumped.

She bowed vigorously to Zhang Chen and thanked him, and the middle-aged man next to her also thanked Zhang Chen again and again.

Zhang Chen hurriedly helped the father and daughter up, and asked Zhang Yue to transfer 500,000 yuan to them on the spot.

Finally, he also said that if you have any questions, you can come to him at any time, and he will continue to pay attention to the follow-up health of all subjects.

Next, the four subjects were administered, and Zhang Chen and several others followed the whole process.

None of the five subjects showed any abnormalities.

Coupled with Mona's 500,000 condolence fee yesterday, a total of 3 million has been spent so far.

It is equivalent to that this gene therapy drug for cardiovascular disease has already spent a lot of money before it has earned money.

And that's just for the first two days, and this expense doesn't include hospitalization, nutrition, and nursing expenses.

As of today, a total of only a sixth subject has been performed.

There are a total of 100 subjects in the phase I clinical trial, which is equivalent to spending 50 million on condolence payments alone.

Coupled with other expenses such as hospitalization fees, there is no seventy or eighty million in the entire phase I clinical trial that cannot be stopped.

According to the number of subjects, there will be a huge overhead for phase II and phase III clinical trials.

Fortunately, Zhang Chen is not short of this money at this time, and after this drug is launched, he can return the funds at a very fast speed.

While recovering funds, you can also earn large amounts of points.

In fact, points are what Zhang Chen values most at present.

After following the administration of today's five subjects, Zhang Chen took Zhang Yue to rush back to the company.

Tian Wenbin and Jiang Lu chose to stay in the hospital, and they still want to continue to pay attention to the latest data news.

Zhang Chen shook his head and reluctantly agreed.

In fact, you can also get the news in the company as soon as possible.

Zhao Yingbo has agreed to send an additional nurse to be responsible for sorting out the relevant clinical trial data, and promised to send it to their mailbox as soon as possible.

But Tian Wenbin and the others showed their consistent style as scientific researchers at this time.

Anyway, they insisted on waiting for the latest news at the hospital.

There was no way, Zhang Chen took Zhang Yue out of the inpatient department and prepared to go back to the company directly.

But just as the two of them walked to the hospital door.

I saw a large group of people gathered around from afar, not knowing what was going on.

Zhang Chen hurriedly walked into the crowd, only to see an old man lying unconscious on the ground, motionless, and a middle-aged man next to him was very anxious and kept trying to wake him up.

At this time, a group of male doctors came to the scene pushing a single bed, and several of them quickly checked the patient's condition and immediately carried the patient lying on the ground to the stretcher.

The middle-aged man next to the patient asked the doctor anxiously.

"Doctor, may I ask my dad what the hell is going on? Half an hour ago, he was fine at home, but he just said that his head hurt a little, and as soon as he arrived at the hospital door, it was like this, and he didn't wake up no matter how he was called. ”

"I think this symptom should be caused by a large cerebral infarction, don't worry, we will do our best to rescue it." One of the middle-aged doctors said.

When Zhang Chen heard that it was a large-scale cerebral infarction, he hurriedly pulled Zhang Yue to follow.

Because of the company's "Lanyue 001" project, he has done a systematic understanding of cardiovascular diseases.

She knows that large-scale cerebral infarction is one of the more serious acute cardiovascular diseases.

Thrombolysis or thrombectomy should ideally be done within 4 to 5 hours of onset.

If it exceeds 6 hours, then the gods will not be able to do anything.

Missing the golden 6 hours of stroke can lead to long-term bed rest or death.

Zhang Chen didn't want to see such a fresh life, so there was an accident under his nose.

Now that he has the power to save this patient, he will try it.

Even though the company's gene therapy drug is not yet on the market, it can communicate with the patient's family temporarily and try to make the patient one of the subjects of the drug.

Thinking of this, Zhang Chen hurriedly took out his mobile phone and called Zhao Yingbo.